Hemolytic uremic syndrome (HUS) takes 2 forms: diarrheal HUS and nondiarrheal HUS. As its name suggests, diarrheal HUS classically follows an enteric infection. The classic infective organism is the Escherichia coli O157 serotype, although other bacteria, including Shigella species, can produce the verocytotoxin required to cause HUS. The usual clinical course is an episode of bloody diarrhea followed by thrombotic microangiopathy and acute renal failure. Supportive treatment sees recovery of renal function in the vast majority of patients. Most cases occur in children, but all age groups can be affected. Conversely, nondiarrheal HUS may have one of a number of predisposing factors, including drugs, irradiation, and hypertension. It also is well established that mutations in the genes encoding the complement regulator proteins factor H, factor I, and membrane cofactor protein predispose to nondiarrheal HUS. In patients with nondiarrheal HUS, recovery of renal function is much less common. Here, we present a case of HUS after a diarrheal illness in which the patient did not recover renal function in the long term. A novel mutation in exon 23 of the factor H gene was discovered. This is clinically important. If this patient underwent transplantation, he would be expected to have an 80% risk of graft loss at 2 years because of recurrent HUS. We recommend consideration of complement gene mutations in any patient with HUS after a diarrheal episode in which there are unusual features.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2007.08.030DOI Listing

Publication Analysis

Top Keywords

nondiarrheal hus
16
renal function
12
hus
11
hemolytic uremic
8
uremic syndrome
8
diarrheal illness
8
diarrheal hus
8
recovery renal
8
hus diarrheal
8
diarrheal
5

Similar Publications

Article Synopsis
  • Postdiarrheal hemolytic-uremic syndrome (D+HUS) is a serious condition resulting from Shiga toxin-producing E. coli (STEC) infection, with genetic factors influencing the risk but still under-researched.
  • Researchers studied patients with confirmed STEC diarrhea from 2007 to 2012, identifying various genetic markers linked to D+HUS using advanced analyses on 200 gene loci.
  • Twelve genes related to key bodily functions were found to be significantly associated with D+HUS, suggesting that targets for future treatments could lie outside the typical complement pathways.
View Article and Find Full Text PDF

Objective: To assess the clinical spectrum of postdiarrheal hemolytic uremic syndrome (D(+)HUS) hospitalizations and sought predictors of in-hospital death to help identify children at risk of poor outcomes.

Study Design: We assessed clinical variables collected through population-based surveillance of D(+)HUS in children <18 years old hospitalized in 10 states during 1997-2012 as predictors of in-hospital death by using tree modeling.

Results: We identified 770 cases.

View Article and Find Full Text PDF

Hemolytic uremic syndrome.

Handb Clin Neurol

April 2014

Department of Neurology, Loyola University Medical Center, Maywood, IL, USA.

The thrombotic microangiopathies include both hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Although debate exists as to whether these are separate entities or a spectrum of disease, both result in the clinical picture of thrombocytopenia, hemolytic anemia, and varying degrees of renal and neurologic involvement. Etiology of HUS includes diarrheal infection due to Shiga toxin-producing bacteria, complement deficiency, pneumococcal infection, and cobalamin deficiency.

View Article and Find Full Text PDF

Two cases of urinary tract infection caused by Shiga toxin-producing Escherichia coli O157:H7 strains.

Rev Argent Microbiol

October 2012

Departamento de Bacteriología y Virología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.

STEC strains can infect extra-intestinal sites such as the human urinary tract and sometimes cause severe complications. We report two cases of urinary tract infection caused by STEC in two elderly women with comorbidities. Although both strains belonged to the O157:H7 serotype and carried genes associated with severe illness, none of the patients developed hemolytic uremic syndrome (HUS).

View Article and Find Full Text PDF

A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same?

Eur J Pediatr

October 2012

Division of Nephrology, Department of Pediatrics, The Children's Hospital of Philadelphia, 1 Main, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA.

Unlabelled: Atypical hemolytic uremic syndrome (HUS) refers to the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury in the absence of Shiga toxin-producing Escherichia coli exposure or Streptococcus pneumoniae infection. Currently, approximately 50 % of the atypical cases have demonstrable mutations in complement regulatory proteins. Historically, the diagnosis of atypical HUS portends a poor prognosis with a high rate of disease recurrence, progression to end-stage renal disease, and death.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!